博纳生物科技 (Bona Biotech) is a high‑tech company founded in 2012 that specializes in membrane separation and purification, producing membrane products and providing membrane technology solutions. Its product line spans microfiltration, ultrafiltration, nanofiltration and reverse osmosis, with internally developed ceramic, organic and hollow‑fiber membrane elements and assembled membrane modules. The company also develops and manufactures membrane equipment including continuous separation filtration, dynamic crossflow filtration and hollow‑fiber membrane distillation systems. Business efforts are concentrated in the pharmaceutical industry and synthetic biology, with additional deployments in food & beverage, new energy and other sectors. Management emphasizes ongoing innovation across membrane formulation, formation mechanisms, manufacturing processes and equipment, and has developed over 500 membrane applications with 70+ applications currently in R&D (including liposome ethanol removal and yolk antibody concentration processes). The recent financing will support membrane R&D, construction of a new plant and capacity expansion, and nationwide sales channel expansion.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2024